EU Clears Brodalumab (Kyntheum) for Plaque Psoriasis EU Clears Brodalumab (Kyntheum) for Plaque Psoriasis

Brodalumab is for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy.International Approvals
Source: Medscape Dermatology Headlines - Category: Dermatology Tags: Dermatology News Alert Source Type: news
More News: Dermatology | Psoriasis | Skin